Price $7.26 |
Market Cap
1.13B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
3.0
|
P/S
7.4
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
-
|
Op. Cash Flow
-37.3K
|
FCF
-0.2
|
|
Op. Margin
-56.80%
|
Net Margin
-48.60%
|
ROE
-19.50%
|
ROI
-27.90%
|
|
ROA
-15.20%
|
EPS Growth
34.70%
|
Current Ratio
9.6
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Interpace Biosciences Inc (IDXG) | $1.45 | - | - | 4.1M | Strong Buy |
| Chromadex Corp (CDXC) | $3.26 | - | - | 105.8M | Strong Buy |
| Collegium Pharmaceutical Inc (COLL) | $37.62 | - | - | 752M | Strong Buy |
| STRATA Skin Sciences Inc (SSKN) | $3.09 | - | - | 16.4M | Strong Buy |
| Cumberland Pharmaceuticals, In (CPIX) | $1.31 | - | - | 28.7M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
